VELCADE in Previously Treated Patients With Stage IIIB and IV Bronchioloalveolar Carcinoma (BAC) and Adenocarcinoma With BAC Features
This study has been terminated.
(insufficient efficacy)
Sponsor:
Millennium Pharmaceuticals, Inc.
Information provided by:
Millennium Pharmaceuticals, Inc.
ClinicalTrials.gov Identifier:
NCT00117351
First received: June 30, 2005
Last updated: February 16, 2011
Last verified: February 2011
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study has been terminated. |
|---|---|
| Study Completion Date: | July 2007 |
| Primary Completion Date: | June 2007 (Final data collection date for primary outcome measure) |